INFU

InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

Wall Street analysts forecast INFU stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INFU is 13.67 USD with a low forecast of 12.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

InfuSystem Holdings Inc revenue for the last quarter amounts to 36.49M USD, increased 3.31 % YoY.

InfuSystem Holdings Inc. EPS for the last quarter amounts to 0.11 USD, increased 37.50 % YoY.

InfuSystem Holdings Inc (INFU) has 502 emplpoyees as of December 15 2025.

Today INFU has the market capitalization of 187.91M USD.